首页> 外文OA文献 >LBOS 01-04 the true incidence of statin -related adverse events in hypertensive patients revealed by comparison of blinded and un-blinded use of statin in the Anglo-Scandinavian cardiac outcomes trial (ASCOT).

【2h】

LBOS 01-04 the true incidence of statin -related adverse events in hypertensive patients revealed by comparison of blinded and un-blinded use of statin in the Anglo-Scandinavian cardiac outcomes trial (ASCOT).

机译：LBOs 01-04在英国 - 斯堪的纳维亚心脏结局试验（asCOT）中通过比较盲法和非盲法使用他汀类药物显示高血压患者中他汀类药物相关不良事件的真实发生率。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Sever, P; Gupta, A; Thompson, D; Whitehouse, A; Collier, T; Dahlof, B; Poulter, N;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase [J] . Gupta Ajay, Thompson David, Whitehouse Andrew, The Lancet . 2017,第10088期

机译：与未结合的不盲目的不良事件，但没有盲目的他汀类药物治疗，在盎格鲁 - 斯堪的纳维亚心脏成果试验 - 降低手臂（Ascot-LLA）：随机的双盲安慰剂对照试验及其非随机的非盲目延伸阶段
2. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ran [J] . Sever PS, Dahlof B, Poulter NR, Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts . 2004,第Suppla2期

机译：在盎格鲁-斯堪的纳维亚心脏结果试验-降脂臂（ASCOT-LLA）中，胆固醇水平平均或低于平均水平的高血压患者使用阿托伐他汀预防冠心病和中风事件：多中心
3. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ran [J] . Sever PS, Dahlof B, Poulter NR, The Lancet . 2003,第9364期

机译：在盎格鲁-斯堪的纳维亚心脏结果试验-降脂臂（ASCOT-LLA）中，胆固醇水平平均或低于平均水平的高血压患者使用阿托伐他汀预防冠心病和中风事件：多中心
4. Retrograde blood cardioplegia is associated with reduced incidence of Major Adverse Cardiac and Cerebrovascular Events (MACCE) - A prospective, non-randomised observational comparison [C] . Bonde P., Nwaejike N., MacGowan S., International Congress on Coronary Artery Disease . 2009

机译：逆行血液心血管血液与主要不良心脏和脑血管事件（宏）的发病率降低有关 - 期前，非随机的观察性比较
5. EXCESS PRESSURE INTEGRAL PREDICTS CARDIOVASCULAR EVENTS INDEPENDENT OF OTHER RISK FACTORS IN THE CONDUIT ARTERY FUNCTIONAL EVALUATION (CAFE) SUB-STUDY OF ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL (ASCOT) [O] . Justin E Davies, Peter Lacy, Therese Tillin, -1

机译：超压积分预测心血管事件在导管-斯堪的纳维亚人心脏结局试验（ASCOT）的研究中独立于其他风险因素
6. LBOS 01-04 the true incidence of statin -related adverse events in hypertensive patients revealed by comparison of blinded and un-blinded use of statin in the Anglo-Scandinavian cardiac outcomes trial (ASCOT). [O] . Sever, P, Gupta, A, Thompson, D, 2016

机译：LBOs 01-04在英国 - 斯堪的纳维亚心脏结局试验（asCOT）中通过比较盲法和非盲法使用他汀类药物显示高血压患者中他汀类药物相关不良事件的真实发生率。

LBOS 01-04 the true incidence of statin -related adverse events in hypertensive patients revealed by comparison of blinded and un-blinded use of statin in the Anglo-Scandinavian cardiac outcomes trial (ASCOT).

著录项

相似文献

相关主题

期刊订阅